Immuneering Corp Class A
4.87
$
5.62 %
Immuneering Corp se focalise sur le développement de médicaments bioinformatiques pour traiter les maladies causées par des dysfonctionnements du signal cellulaire, notamment le cancer.
Price history of Immuneering Corp Class A
Price history of Immuneering Corp Class A
Performance & Momentum
6 Months
32.08 %
1 Year
220.39 %
3 Years
49.79 %
5 Years
72.31 %
Similar stocks to Immuneering Corp Class A
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
